awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35947278-EA5091BE-9D26-4037-BC61-3C0462E19677
Q35947278-EA5091BE-9D26-4037-BC61-3C0462E19677
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35947278-EA5091BE-9D26-4037-BC61-3C0462E19677
Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.
P2860
Q35947278-EA5091BE-9D26-4037-BC61-3C0462E19677
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35947278-EA5091BE-9D26-4037-BC61-3C0462E19677
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70f26daf7dbd4107705c0e6788b881ff8f89cb73
P2860
Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanoma.